Library / Laws / 114th Congress / Senate Bills / S. 2019
S. 2019
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2015-09-09 | 16.3K | ⠃⠗⠋ |